Free Trial

Teacher Retirement System of Texas Makes New $1.01 Million Investment in DaVita Inc. (NYSE:DVA)

DaVita logo with Medical background

Teacher Retirement System of Texas purchased a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,602 shares of the company's stock, valued at approximately $1,010,000.

A number of other large investors have also recently bought and sold shares of the stock. UMB Bank n.a. boosted its stake in DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Copia Wealth Management acquired a new position in DaVita in the fourth quarter worth $30,000. Coppell Advisory Solutions LLC boosted its stake in DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Canada Post Corp Registered Pension Plan acquired a new position in DaVita in the fourth quarter worth $55,000. Finally, Jones Financial Companies Lllp boosted its stake in DaVita by 28.6% in the fourth quarter. Jones Financial Companies Lllp now owns 517 shares of the company's stock worth $77,000 after purchasing an additional 115 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Truist Financial reduced their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $164.50.

Check Out Our Latest Stock Analysis on DaVita

DaVita Trading Up 2.2%

NYSE:DVA traded up $3.13 during mid-day trading on Thursday, hitting $143.35. The company had a trading volume of 578,712 shares, compared to its average volume of 810,777. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60. The business's fifty day moving average is $140.16 and its two-hundred day moving average is $148.63. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. The firm has a market cap of $10.82 billion, a P/E ratio of 14.21, a P/E/G ratio of 0.98 and a beta of 1.11.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The firm had revenue of $3.22 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same quarter in the prior year, the firm posted $2.26 earnings per share. The company's quarterly revenue was up 5.0% on a year-over-year basis. As a group, research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines